Figure of 8 Walk Test in Multiple Sclerosis

Sponsor
Kahramanmaras Sutcu Imam University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05433714
Collaborator
(none)
50
1
2.5
20.3

Study Details

Study Description

Brief Summary

Balance disorder is common in people with MS. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. Given the prevalence and clinical significance of balance dysfunction in individuals with MS, the assessment of balance has become an important focus in MS clinical practice and research. The figure of 8 Walk Test is a standard clinical measure used to evaluate the forward walking performance required in daily life. Beyond walking straight, turning ability is required in many situations in daily life such as walking around a table, avoiding obstacles and navigating the street. The gait characteristics of walking on a straight and curved road are different. During curved walking, the center of mass of the body shifts to the inner leg as the stance time of the inner leg increases, as opposed to walking on a straight track. Compared to other standardized tests, scoring is not dependent on the subjectivity of the examiner, can be administered by a person with minimal training, and requires minimal time, space, and equipment. The test assesses the ability to quickly change direction of movement and is a timed test involving the use of assistive devices.

Condition or Disease Intervention/Treatment Phase
  • Other: Assesment

Detailed Description

Multiple sclerosis (MS) is a progressive disease of the central nervous system characterized by demyelination and destruction of motor and sensory axons. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. The prevalence of balance dysfunction in individuals with MS and Given its clinical relevance, the assessment of balance has become an important focus in MS clinical practice and research. The figure of 8 Walk Test is a standard clinical measure used to evaluate the forward walking performance required in daily life.In the figure of 8 walk test, two cones are placed 1.5 meters apart. The individual stands in the middle of this distance. At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone. The elapsed time is recorded.

The aim of the study is to examine the validity and reliability of the 8-shape walking test in MS patients.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
50 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
The Reliability and Validity of the Figure of 8 Walk Test in Multiple Sclerosis
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Oct 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Multiple sclerosis patient

First day, first evaluator will perform all tests, and second day, second evaluator will perform the figure of 8 walk test.

Other: Assesment
The figure of walk test, Berg Balance scale, Timed 25-Foot Walk, Timed up and go test, Foursquare walk test

Outcome Measures

Primary Outcome Measures

  1. The Figure of Walk Test [First day]

    Two cones are placed 1.5 meters apart. The individual stands in the middle of this distance. At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone. Elapsed time is recorded

  2. The Figure of Walk Test [second day]

    Two cones are placed 1.5 meters apart. The individual stands in the middle of this distance. At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone. Elapsed time is recorded

Secondary Outcome Measures

  1. Berg Balance scale [First day]

    It is a 14-item scale that measures the ability to maintain balance while performing functional tasks. Each item is scored between 0 and 4. Balance is considered good if the total score is 45 and above.

  2. Timed up and go test [First day]

    At the beginning of the test, individuals sit in a chair. A distance of 3 m is set in front of it. With the start command, he gets up from his seat and walks 3 m, turns around and walks back and sits. With the start command, the time to sit on the chair is recorded in seconds. Short duration indicates good functional mobility.

  3. Timed 25-Foot Walk test [First day]

    It is an evaluation to evaluate mobility and leg functions. Individuals are asked to safely walk 7.62 m on a flat surface at their highest speed.

  4. Four Square Step Test [First day]

    It aims to assess dynamic balance and step objects forward, sideways and backwards. The square drawn on the floor is divided into 4 equal parts. The number 1 is written in the lower right corner, up to 4 clockwise. With the start command, individuals are asked to step on the numbers in order.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Having an EDSS score of 4 and below,

  • Being between the ages of 18-65

  • Willingness to participate in the study

Exclusion Criteria:
  • Being pregnant or within the first 3 months after giving birth,

  • Receiving corticosteroid therapy in the last 1 month,

  • Using drugs that will affect walking in the last 1 month

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kahramanmaraş Sutcu Imam University Kahramanmaraş Turkey

Sponsors and Collaborators

  • Kahramanmaras Sutcu Imam University

Investigators

  • Principal Investigator: Zekiye İpek Katırcı Kırmacı, Kahramanmaraş Sütçü İmam University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zekiye İpek KATIRCI KIRMACI, Asst. Prof., Kahramanmaras Sutcu Imam University
ClinicalTrials.gov Identifier:
NCT05433714
Other Study ID Numbers:
  • ipekkrmc
First Posted:
Jun 27, 2022
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zekiye İpek KATIRCI KIRMACI, Asst. Prof., Kahramanmaras Sutcu Imam University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2022